The innovative drug concept continues to strengthen, Sunshine Guojian Pharmaceutical has achieved 4 consecutive limit-ups
Sunshine Guojian Pharmaceutical has achieved a 20CM four consecutive limit up, Hicin Pharmaceutical has risen over 10%, and Shutai Shen, HISOAR, Ruizhi Pharmaceutical, SHANGHAI YIZHONG, and others have seen significant gains